Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015)

Gilead Sciences (GILD) posted Preferred Stock Liabilities of $2.0 million for Q4 2015, down 50.0% quarter-over-quarter from $4.0 million in Q3 2015, and down 86.67% year-on-year from $15.0 million in Q4 2014.

Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015) Analysis & Trends

Gilead Sciences (GILD) has reported Preferred Stock Liabilities for 4 consecutive years, with $2.0 million the latest figure, recorded in Q4 2015.

  • Preferred Stock Liabilities for Q4 2015 came in at $2.0 million, down 86.67% year-over-year; the trailing twelve-month figure through Dec 2015 was $2.0 million (down 86.67% YoY), and the FY2015 annual result was $2.0 million, down 86.67% from the prior year.
  • Preferred Stock Liabilities was $2.0 million for Q4 2015 at Gilead Sciences, down from $4.0 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $64.0 million in Q4 2013 and troughed at $2.0 million in Q4 2015.
  • Average Preferred Stock Liabilities over 4 years is $21.9 million, with a median of $13.0 million recorded in 2014.
  • Year-over-year, Preferred Stock Liabilities jumped 795.48% in 2013 and tumbled 86.67% in 2015.
  • Over 4 years, Preferred Stock Liabilities stood at $7.1 million in 2012, then jumped by 795.48% to $64.0 million in 2013, then plunged by 76.56% to $15.0 million in 2014, then sank by 86.67% to $2.0 million in 2015.
  • Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $2.0 million in Q4 2015, $4.0 million in Q3 2015, and $7.0 million in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 2.00 Mn
Sep 30, 2015 4.00 Mn
Jun 30, 2015 7.00 Mn
Mar 31, 2015 11.00 Mn
Dec 31, 2014 15.00 Mn
Sep 30, 2014 27.38 Mn
Jun 30, 2014 35.88 Mn
Mar 31, 2014 45.77 Mn
Dec 31, 2013 64.00 Mn
Dec 31, 2012 7.15 Mn